Targeted engagement of CTLA‐4 prevents autoimmune thyroiditis
The CTLA‐4‐mediated signal is a critical step in the down‐modulation of immune responses. The therapeutic potential of this signal to induce tissue‐specific tolerance was investigated by using an anti‐CTLA‐4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in viv...
Saved in:
Published in | International immunology Vol. 15; no. 5; pp. 641 - 654 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.05.2003
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The CTLA‐4‐mediated signal is a critical step in the down‐modulation of immune responses. The therapeutic potential of this signal to induce tissue‐specific tolerance was investigated by using an anti‐CTLA‐4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb‐treated mice showed a significant reduction in their ability to proliferate, and to produce IL‐2, IFN‐γ and tumor necrosis factor (TNF)‐α, in response to mTg re‐stimulation compared to lymphocytes from untreated mice. Moreover, BiAb‐treated mice showed suppressed anti‐mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA‐4, resulting in an increase in the number of CD4+CD25+ T cells. These regulatory T cells suppressed in vitro mTg‐specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)‐β1 production. Neutralization of TGF‐β1 increased mTg‐specific in vitro proliferation of, and IL‐2 production by, T cells from BiAb‐treated mice. Our data suggest that engagement of CTLA‐4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF‐β1, with a concomitant reduction in IFN‐γ and TNF‐α, resulting in suppression of EAT. |
---|---|
AbstractList | The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue-specific tolerance was investigated by using an anti-CTLA-4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb-treated mice showed a significant reduction in their ability to proliferate, and to produce IL-2, IFN-gamma and tumor necrosis factor (TNF)-alpha, in response to mTg re-stimulation compared to lymphocytes from untreated mice. Moreover, BiAb-treated mice showed suppressed anti-mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA-4, resulting in an increase in the number of CD4(+)CD25(+) T cells. These regulatory T cells suppressed in vitro mTg-specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)-beta1 production. Neutralization of TGF-beta1 increased mTg-specific in vitro proliferation of, and IL-2 production by, T cells from BiAb-treated mice. Our data suggest that engagement of CTLA-4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF-beta1, with a concomitant reduction in IFN-gamma and TNF-alpha, resulting in suppression of EAT. The CTLA‐4‐mediated signal is a critical step in the down‐modulation of immune responses. The therapeutic potential of this signal to induce tissue‐specific tolerance was investigated by using an anti‐CTLA‐4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb‐treated mice showed a significant reduction in their ability to proliferate, and to produce IL‐2, IFN‐γ and tumor necrosis factor (TNF)‐α, in response to mTg re‐stimulation compared to lymphocytes from untreated mice. Moreover, BiAb‐treated mice showed suppressed anti‐mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA‐4, resulting in an increase in the number of CD4+CD25+ T cells. These regulatory T cells suppressed in vitro mTg‐specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)‐β1 production. Neutralization of TGF‐β1 increased mTg‐specific in vitro proliferation of, and IL‐2 production by, T cells from BiAb‐treated mice. Our data suggest that engagement of CTLA‐4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF‐β1, with a concomitant reduction in IFN‐γ and TNF‐α, resulting in suppression of EAT. The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue-specific tolerance was investigated by using an anti-CTLA-4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb-treated mice showed a significant reduction in their ability to proliferate, and to produce IL-2, IFN-[gamma] and tumor necrosis factor (TNF)-[alpha], in response to mTg re-stimulation compared to lymphocytes from untreated mice. Moreover, BiAb-treated mice showed suppressed anti-mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA-4, resulting in an increase in the number of CD4+CD25+ T cells. These regulatory T cells suppressed in vitro mTg-specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)-[beta]1 production. Neutralization of TGF-[beta]1 increased mTg-specific in vitro proliferation of, and IL-2 production by, T cells from BiAb-treated mice. Our data suggest that engagement of CTLA-4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF-[beta]1, with a concomitant reduction in IFN-[gamma] and TNF-[alpha], resulting in suppression of EAT. The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue- specific tolerance was investigated by using an anti-CTLA-4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb-treated mice showed a significant reduction in their ability to proliferate, and to produce IL-2, IFN- gamma and tumor necrosis factor (TNF)- alpha , in response to mTg re-stimulation compared to lymphocytes from untreated mice. Moreover, BiAb- treated mice showed suppressed anti-mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA-4, resulting in an increase in the number of CD4 super(+)CD25 super(+) T cells. These regulatory T cells suppressed in vitro mTg-specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)- beta 1 production. Neutralization of TGF- beta 1 increased mTg-specific in vitro proliferation of, and IL-2 production by, T cells from BiAb-treated mice. Our data suggest that engagement of CTLA-4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF- beta 1, with a concomitant reduction in IFN- gamma and TNF- alpha , resulting in suppression of EAT. |
Author | Holterman, Mark J. Gorla, Seema R. Vasu, Chenthamarakshan Prabhakar, Bellur S. |
Author_xml | – sequence: 1 givenname: Chenthamarakshan surname: Vasu fullname: Vasu, Chenthamarakshan organization: Department of Surgery and – sequence: 2 givenname: Seema R. surname: Gorla fullname: Gorla, Seema R. organization: Department of Surgery and – sequence: 3 givenname: Bellur S. surname: Prabhakar fullname: Prabhakar, Bellur S. organization: Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA – sequence: 4 givenname: Mark J. surname: Holterman fullname: Holterman, Mark J. organization: Department of Surgery and |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12697664$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0MtKAzEUBuAgFa2XpVsZXLgbTSa3ZiW1eMOCCyuIm5DpnNSpnZmaZKTufASf0Scx0mLBjatA8vGfk38HdeqmBoQOCD4hWNHTsg5lVZ0WiwkWZAN1CRM4zaiUHdTFitO0R2RvG-14P8UY00zRLbRNMqGkEKyLzkbGTSBAkUA9MROooA5JY5PBaNj_-vhkydzBW7zziWlDEye1NSTh-d01ZVGG0u-hTWtmHvZX5y56uLwYDa7T4d3VzaA_TMeM05BSDsQoTmie5TKP20kBGTFAc8alVYxAUWSMUNtj2GIrDFE5JkoUFgtmeU530fEyd-6a1xZ80FXpxzCbmRqa1mtJicoUE__CyDIiKY_w6A-cNq2r4yei4ZhyjnsRpUs0do33Dqyeu7Iy7l0TrH_618v-9bL_6A9XoW1eQbHWq8LXgaUPsPh9N-5FC0kl19ePT1pc4vvb8xHXj_QbAbKTVA |
CitedBy_id | crossref_primary_10_1189_jlb_0803394 crossref_primary_10_3389_fimmu_2024_1387975 crossref_primary_10_1038_nbt1345 crossref_primary_10_1016_j_molmed_2004_01_009 crossref_primary_10_1210_en_2008_1389 crossref_primary_10_1080_08916930310001603073 crossref_primary_10_1210_jc_2005_2337 crossref_primary_10_1586_1744666X_3_2_217 crossref_primary_10_1186_1471_2431_13_123 crossref_primary_10_4049_jimmunol_173_4_2866 crossref_primary_10_4049_jimmunol_170_11_5511 crossref_primary_10_4049_jimmunol_0903130 crossref_primary_10_1038_s41388_022_02209_w crossref_primary_10_1016_j_jneuroim_2003_12_003 crossref_primary_10_4049_jimmunol_179_8_5191 crossref_primary_10_1111_imm_13476 crossref_primary_10_4196_kjpp_2012_16_5_349 crossref_primary_10_1016_j_ddtec_2021_08_006 crossref_primary_10_4161_mabs_26390 crossref_primary_10_4049_jimmunol_180_10_6566 crossref_primary_10_1089_thy_2007_0406 crossref_primary_10_3389_fimmu_2023_1198365 crossref_primary_10_1021_jacs_2c00129 crossref_primary_10_1016_j_ymthe_2006_03_021 crossref_primary_10_1038_s41598_019_48464_y crossref_primary_10_1016_j_ejim_2012_07_007 crossref_primary_10_1097_01_mot_0000130144_06730_ea crossref_primary_10_1016_j_clim_2014_04_014 crossref_primary_10_1016_j_jaut_2009_03_010 crossref_primary_10_1016_j_jaut_2009_09_004 |
ContentType | Journal Article |
Copyright | Copyright Oxford University Press(England) May 2003 |
Copyright_xml | – notice: Copyright Oxford University Press(England) May 2003 |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7QP 7QR 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
DOI | 10.1093/intimm/dxg061 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Virology and AIDS Abstracts MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1460-2377 |
EndPage | 654 |
ExternalDocumentID | 345531061 10_1093_intimm_dxg061 12697664 ark_67375_HXZ_6F0SKBT5_X |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: K08 AI01821-01A2 |
GroupedDBID | --- -E4 .2P .55 .GJ .I3 .ZR 0R~ 18M 1TH 29J 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6.Y 70D A8Z AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT ABEJV ABEUO ABIXL ABJNI ABKDP ABMNT ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACIWK ACMRT ACPQN ACPRK ACUFI ACUTJ ACUTO ACYHN ACZBC ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFGWE AFIYH AFOFC AFRAH AFSHK AFXAL AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AGUTN AHMBA AHXPO AI. AIAGR AIJHB AJEEA AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVNTJ AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSCLL BSWAC BTRTY BVRKM BZKNY C1A C45 CAG CDBKE COF CS3 CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBD EBS EE~ EIHJH EJD ELUNK EMOBN ENERS ESTFP F5P F9B FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK FRP GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 J8S JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN M-Z M49 MBLQV MBTAY MHKGH N9A NGC NLBLG NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OBC OBOKY OBS OCZFY ODMLO OEB OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TCN TEORI TJX TLC TMA TR2 UDS VH1 W8F WOQ X7H X7M Y6R YAYTL YHZ YKOAZ YXANX ZKX ~91 CGR CUY CVF ECM EIF NPM AASNB AAYXX CITATION 7QL 7QP 7QR 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
ID | FETCH-LOGICAL-c453t-35e1a9513b2b7b37776e21ae3b457f941edd2413f840f0f6a19b0196df064f5b3 |
ISSN | 0953-8178 1460-2377 |
IngestDate | Fri Oct 25 06:51:05 EDT 2024 Sat Oct 26 01:44:05 EDT 2024 Wed Nov 06 08:26:01 EST 2024 Thu Sep 12 20:00:41 EDT 2024 Wed Oct 16 00:51:16 EDT 2024 Wed Oct 30 09:52:56 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c453t-35e1a9513b2b7b37776e21ae3b457f941edd2413f840f0f6a19b0196df064f5b3 |
Notes | local:dxg061 istex:B26988A79D5369C2414BF203B2C91C2D83999FC5 ark:/67375/HXZ-6F0SKBT5-X Correspondence to: M. J. Holterman; E‐mail: rmasjet@uic.edu Transmitting editor: E. R. Unanue ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://academic.oup.com/intimm/article-pdf/15/5/641/1860601/dxg061.pdf |
PMID | 12697664 |
PQID | 195035508 |
PQPubID | 34171 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_73192946 proquest_miscellaneous_19221735 proquest_journals_195035508 crossref_primary_10_1093_intimm_dxg061 pubmed_primary_12697664 istex_primary_ark_67375_HXZ_6F0SKBT5_X |
PublicationCentury | 2000 |
PublicationDate | 2003-05 2003-May 2003-5-1 20030501 |
PublicationDateYYYYMMDD | 2003-05-01 |
PublicationDate_xml | – month: 05 year: 2003 text: 2003-05 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | International immunology |
PublicationTitleAlternate | Int. Immunol |
PublicationYear | 2003 |
Publisher | Oxford University Press Oxford Publishing Limited (England) |
Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
SSID | ssj0003293 |
Score | 1.9249142 |
Snippet | The CTLA‐4‐mediated signal is a critical step in the down‐modulation of immune responses. The therapeutic potential of this signal to induce tissue‐specific... The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue-specific... The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue- specific... |
SourceID | proquest crossref pubmed istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 641 |
SubjectTerms | anergy Animals Antibodies, Bispecific - blood Antibodies, Bispecific - immunology Antigens, CD Antigens, Differentiation - immunology autoimmunity co‐stimulation CTLA-4 Antigen Female immune suppression Interleukin-10 - metabolism Mice Mice, Inbred CBA Serum - immunology Signal Transduction - immunology T lymphocyte Thymus Gland - immunology Thyroid Gland - immunology Thyroiditis, Autoimmune - immunology Thyroiditis, Autoimmune - metabolism Thyroiditis, Autoimmune - prevention & control tolerance Transforming Growth Factor beta - metabolism |
Title | Targeted engagement of CTLA‐4 prevents autoimmune thyroiditis |
URI | https://api.istex.fr/ark:/67375/HXZ-6F0SKBT5-X/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/12697664 https://www.proquest.com/docview/195035508 https://search.proquest.com/docview/19221735 https://search.proquest.com/docview/73192946 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgE4gXBANGGZc8IN7CkviS5HGgdRV0A2kpinixnMZZq20JShO08es5tpO4FUxcXqIocZ3U58vx53MzQq8lkTiieeF680y4JAipG0sZuTQmBG4pX6dKTj4-YZMZ-ZDS1O6xqbNLmuzt_Mdv80r-R6pwDeSqsmT_QbJDp3ABzkG-cAQJw_HvZKzDuIEyyvKsC2LR4RXJ9MAlKv3_u85fE21TLVUeiASaeV1Xy1wVMlqnpZt2Qd12w9z-Raxa45yHDhfiUtTifLWwwDqq6gvNQk-lvBQ2CPFzLbKFODdB3CoVqK2trXVSXeh5oexzhjoXVW-DWIv4G4yJ2I18sxnPoFfpGn7ompJkptRVN98yU0T6F1Vuylwtywb-NJzkV2ce8-2s1XvqTz7x8Ww65clhmtxG2wHoG6XojlIb6YMDU3u5f8mu1Co8YN90v28636Am2-oru7p53aH5R_IA3e8WDs6BQcFDdEuWO-iO2Ur0egfdPe6CJB6hARaOhYVTFY6BhdPDwrGwcNZg8RjNxofJ-4nb7ZLhzgnFjYup9AXwZJwFWZjhMAyZDHwhcUZoWMTEl3munKcFLOULr2DCjzNVFCkvgI0WNMNP0FZZlfIpchQ3oSJgspCCCBaJWDFSYNTCw0UYRSP0ph8g_s0UQ-EmiAFzM5LcjCQ01MM3tAIMqQjCkPJJ-pWzsXf68V1CeTpCe_348u7DWnG1MzHQYA-e92q4C1pPubJEKatWNQlgLY3pzS1CmFuCmLAR2jVis28cMODgjDz742_30D2L9udoq6lb-QI4aJO91Aj7CQAdimE |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeted+engagement+of+CTLA-4+prevents+autoimmune+thyroiditis&rft.jtitle=International+immunology&rft.au=Vasu%2C+Chenthamarakshan&rft.au=Gorla%2C+Seema+R&rft.au=Prabhakar%2C+Bellur+S&rft.au=Holterman%2C+Mark+J&rft.date=2003-05-01&rft.issn=0953-8178&rft.volume=15&rft.issue=5&rft.spage=641&rft.epage=654&rft_id=info:doi/10.1093%2Fintimm%2Fdxg061&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0953-8178&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0953-8178&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0953-8178&client=summon |